Cargando…

Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer

Detalles Bibliográficos
Autor principal: Shen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299539/
https://www.ncbi.nlm.nih.gov/pubmed/30563572
http://dx.doi.org/10.1186/s40880-018-0344-6
_version_ 1783381505456734208
author Shen, Lin
author_facet Shen, Lin
author_sort Shen, Lin
collection PubMed
description
format Online
Article
Text
id pubmed-6299539
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62995392018-12-31 Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer Shen, Lin Cancer Commun (Lond) Research Highlight BioMed Central 2018-12-18 /pmc/articles/PMC6299539/ /pubmed/30563572 http://dx.doi.org/10.1186/s40880-018-0344-6 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Highlight
Shen, Lin
Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer
title Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer
title_full Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer
title_fullStr Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer
title_full_unstemmed Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer
title_short Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer
title_sort liquid biopsy: a powerful tool to monitor trastuzumab resistance in her2-positive metastatic gastric cancer
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299539/
https://www.ncbi.nlm.nih.gov/pubmed/30563572
http://dx.doi.org/10.1186/s40880-018-0344-6
work_keys_str_mv AT shenlin liquidbiopsyapowerfultooltomonitortrastuzumabresistanceinher2positivemetastaticgastriccancer